Interaction of protease inhibitors with the catalytic subunit of cAMP-dependent protein kinase.
D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology*; D000818:Animals; D000976:Antipain / Q000494:pharmacology; D002021:Buffers; D000242:Cyclic AMP / Q000378:metabolism*; D004121:Dimethyl Sulfoxide; D007976:Leupeptins / Q000494:pharmacology; D046911:Macromolecular Substances; D000432:Methanol; D009132:Muscles / Q000201:enzymology*; D011092:Polyethylene Glycols; D011480:Protease Inhibitors / Q000378:metabolism* / Q000494:pharmacology; D011494:Protein Kinases / Q000378:metabolism*; D051381:Rats; D012995:Solubility; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology*; D014108:Tosylphenylalanyl Chloromethyl Ketone / Q000494:pharmacology*
D000590:Amino Acid Chloromethyl Ketones; D002021:Buffers; D007976:Leupeptins; D046911:Macromolecular Substances; D011480:Protease Inhibitors; D014107:Tosyllysine Chloromethyl Ketone; D000976:Antipain; D011092:Polyethylene Glycols; D014108:Tosylphenylalanyl Chloromethyl Ketone; D000242:Cyclic AMP; D011494:Protein Kinases; D000432:Methanol; D004121:Dimethyl Sulfoxide